By Timothy S. Donahue
Top Takeaways:
New authorizations: FDA clears four Glas ENDS pods, including non-tobacco flavors
Tech focus: Approval hinges on device-level age verification and access controls
Regulatory signal: Opens pathway for flavored products tied to youth mitigation
The U.S. Food and Drug Administration has authorized four Glas electronic nicotine delivery system (ENDS) products through the premarket tobacco product application (PMTA) pathway, marking the agency’s first authorization of non-tobacco, non-menthol flavored e-cigarettes that include device-level age-restriction technology.
The authorized products receiving the marketing granted orders (MGOs) are Classic Menthol, Fresh Menthol, Gold (Mango), and Sapphire (Blueberry). The 5% nicotine e-liquid pods are now permitted for legal sale in the United States to adults 21 and older.
Glas, a small U.S. manufacturer not owned by a major tobacco company, stated it was “pleased” that it received MGOs from the FDA for the additional flavored G2 products. “This outcome reflects years of investment in science, product development, and regulatory engagement,” the company stated in an email to Nicotine Insider. “Our data show that flavored products can play an important role in helping adult smokers move away from combustible cigarettes, while our technology is designed to help limit youth access and support responsible use.
“We recognize that these authorizations come with strict requirements and ongoing FDA oversight, and we support that framework. Glas has built our platform to meet these expectations, including strong marketing controls and post-market monitoring.
“Today’s decision is an important step forward – not only for Glas, but for a clear, science-based path for responsible innovation in the United States. We will continue to work with FDA as we advance the remainder of our G2 portfolio and remain committed to delivering compliant, science-backed alternatives for adult smokers.”
The system requires users to verify their age and identity with a government-issued ID and to pair the device with a smartphone via Bluetooth. The device will not function if it is separated from the verified phone. The associated app conducts periodic biometric checks to confirm the authorized user.
“By helping to prevent youth use, device access restrictions are a potential game changer,” said Bret Koplow, acting director for the FDA’s Center for Tobacco Products (CTP). “This technology is also an indication of the role innovation may serve in the effort to protect young people from threats posed by nicotine use and addiction while helping to enable availability of an expanded array of flavored options for adults who smoke who may use these products to completely switch away from regular cigarettes.”
FDA said the applicant demonstrated that most adults were able to complete the verification process and use the system, whereas youth and young adults were not.
The agency added that the authorization provides “an additional way” for non-tobacco-flavored products to meet regulatory standards when youth risks are mitigated and adult benefits outweigh those risks.
The marketing orders also impose strict conditions, requiring the company to target advertising only to adults 21 and older and to track and report on the effectiveness of youth-prevention measures, including demographic data on the audiences reached.
The FDA emphasized that the authorizations apply only to the four specific Glas products and do not extend to other products in the company’s portfolio.
With the decision, the agency said it has now authorized 45 ENDS products for legal sale in the U.S., reinforcing a still-limited pathway for vapor products under federal review.
At the same time, the FDA said it will continue enforcement against unauthorized products, including joint operations with federal partners and actions targeting retailers that fail to comply with regulations.
Behind the scenes
It’s hard to know whether the latest news about the agency not initially authorizing the Glas flavored products impacted the decision, given that CTP scientists had previously recommended the flavored pods for authorization.
Company emails and FDA memos obtained through a Freedom of Information Act request showed that the CTP’s Office of Science (OS) initially advised granting marketing orders for all eight SKUs on Dec. 18, 2025.
In a separate memo dated March 11, Koplow wrote that Principal Deputy Commissioner Sara Brenner had then instructed the agency on Feb. 19 (scroll down) to “refrain from issuing” MGOs for the four flavored pod products: Gold, Sapphire, Fresh Menthol, and Classic Menthol. The result was that the FDA issued MGOs only for the Glas G2 device and the Blonde Tobacco pod on March 12.
Glas is the only non-tobacco affiliated company to receive an ENDS marketing order. Today, it seems the FDA has altered its course on flavored vapes and potentially the future of the vaping industry.
